CA2343572C - Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein - Google Patents
Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein Download PDFInfo
- Publication number
- CA2343572C CA2343572C CA002343572A CA2343572A CA2343572C CA 2343572 C CA2343572 C CA 2343572C CA 002343572 A CA002343572 A CA 002343572A CA 2343572 A CA2343572 A CA 2343572A CA 2343572 C CA2343572 C CA 2343572C
- Authority
- CA
- Canada
- Prior art keywords
- breast cancer
- vitamin
- gene
- vdr
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne une méthode de détermination de la prédisposition d'un individu au cancer du sein, du développement du cancer du sein et/ou de la réactivité au traitement du cancer du sein. Ledit procédé consiste à déterminer le génotype du récepteur de la vitamine D de l'individu, la prédisposition de l'individu au cancer du sein, le développement du cancer du sein et/ou la réactivité au traitement du cancer du sein.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10044898P | 1998-09-15 | 1998-09-15 | |
US60/100,448 | 1998-09-15 | ||
PCT/CA1999/000853 WO2000015835A2 (fr) | 1998-09-15 | 1999-09-15 | Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2343572A1 CA2343572A1 (fr) | 2000-03-23 |
CA2343572C true CA2343572C (fr) | 2008-01-22 |
Family
ID=22279822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002343572A Expired - Fee Related CA2343572C (fr) | 1998-09-15 | 1999-09-15 | Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1114180A2 (fr) |
AU (1) | AU5723299A (fr) |
CA (1) | CA2343572C (fr) |
WO (1) | WO2000015835A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6270094B1 (en) | 1999-03-26 | 2001-08-07 | William F. Campbell | Multi-purpose wire dispensing cart |
-
1999
- 1999-09-15 EP EP99944189A patent/EP1114180A2/fr not_active Withdrawn
- 1999-09-15 CA CA002343572A patent/CA2343572C/fr not_active Expired - Fee Related
- 1999-09-15 AU AU57232/99A patent/AU5723299A/en not_active Abandoned
- 1999-09-15 WO PCT/CA1999/000853 patent/WO2000015835A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000015835A3 (fr) | 2000-07-13 |
CA2343572A1 (fr) | 2000-03-23 |
AU5723299A (en) | 2000-04-03 |
WO2000015835A2 (fr) | 2000-03-23 |
EP1114180A2 (fr) | 2001-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0821733B1 (fr) | Marqueurs genetiques pour le cancer du sein et des ovaires | |
US9909189B2 (en) | Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues | |
EP1690948A2 (fr) | Detection spécifique de la méthylation | |
JP2002505888A (ja) | 唾液分析による新生物の検出 | |
AU720500B2 (en) | Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 | |
US6444427B1 (en) | Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof | |
CA2343572C (fr) | Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein | |
US20060040263A1 (en) | Marker at the androgen receptor gene for determining breast cancer susceptibility | |
EP1394268A1 (fr) | HNF1alpha en tant que suppresseur de tumeur et utilisation thérapeutiques et diagnostiques de celle-ci | |
CA2343049A1 (fr) | Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose | |
WO2001073116A2 (fr) | Methode permettant de determiner la probabilite d'etre atteint d'osteoporose et/ou une faible densite osseuse, et reactifs destines a cette methode | |
JP2001518311A (ja) | 遺伝子座の階層化による疾病の関連づけ | |
WO2002006522A2 (fr) | Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible | |
AU5645200A (en) | Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 | |
WO2005033339A1 (fr) | Polymorphisme du gene du recepteur de type toll-3 humain utilise en tant que marqueur du facteur herite d'une maladie allergique et utilisation de ce marqueur | |
JP2007503806A (ja) | ヒト肥満感受性遺伝子およびその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20160915 |